Heinz Läubli

Heinz is a professor for cellular cancer immunotherapy at the University of Basel. He is a senior attending oncologist at the University Hospital in Basel and leading the cell therapy program for solid tumors. His main research goal is the improvement of cancer immunotherapy by targeting glycan-mediated immunosuppression.